A comparison of false positive rates of Peto and poly-3 methods for long-term carcinogenicity data analysis using multiple comparison adjustment method suggested by Lin and Rahman

Journal of Biopharmaceutical Statistics

Volumn 18, Issue 5, 2008, Pages 949-958

  Rahman, Mohammad A ^a   Lin, Karl K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Carcinogenicity; Dose response; False positive rate; Peto test; Poly K test

Indexed keywords

BENZENE; NEW DRUG; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CARCINOGENICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FALSE POSITIVE RESULT; FEMALE; FIBROMA; LONG TERM EXPOSURE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PETO TEST; POLY K TEST; PRIORITY JOURNAL; RAT; SKIN TUMOR; STATISTICAL ANALYSIS; SURVIVAL RATE; TRANSGENIC MOUSE;

ANIMALS; CARCINOGENICITY TESTS; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; NEOPLASMS, EXPERIMENTAL;

EID: 51649131434     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400802287628     Document Type: Article

References (17)

1. Ahn, H., Kodell, R. L. (1995). Estimation and testing of tumor incidence rates in experiments lacking cause-of-death data. Biometrical Journal 37:745-763.
2. Ahn, H., Kodell, R. L., Moon, H. (2000). Attribution of tumor lethality and estimation of time to onset of occult tumors in the absence of cause-of-death information. Appl. Stat. 49:157-169.
3. Armitage, P. (1955). Tests for linear trends in proportions and frequencies. Biometrics 11:375-386.
4. Armitage, P. (1971). Statistical Methods in Medical Research. New York: John Wiley.
5. Bailer, A., Portier, C. (1988). Effects of treatment-induced mortality on tests for carcinogenicity in small samples. Biometrics 44:417-431.
6. Bieler, G. S., Williams, R. L. (1993). Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics 49:793-801.
7. Chen, J. J., Lin, K. K., Huque, M. F., Arani, R. B. (2000). Weighted P-value for animal carcinogenicity trend test. Biometrics 56:586-592.
8. 2 tests. Biometrics 10:417-451.
9. Dinse, G. E. (1985). Testing for a trend in tumor prevalence rates. I. Nonlethal Tumors. Biometrics 41:751-770.
10. Haseman, Haseman, J. K. (1984a). Statistical issues in the design, analysis and interpretation of animal carcinogenicity studies. Environmental Health Perspective 58:385-392.
11. International Conference on Harmonization. (1998). S1B testing for carcinogenicity of pharmaceuticals, ICH-S1B. Fed. Reg. 63:8983-8986.
12. Lin, K. K. (2000). Carcinogenicity studies of pharmaceuticals. In: Chow, S. C., ed. Encyclopedia of Biopharmaceutical Statistics. New York: Marcel Dekker, pp. 88-103.
13. Lin, K. K., Rahman, M. A. (1998). Overall false positive rates in tests for linear trend in tumor incidence in animal carcinogenicity studies of new drugs. J. Biopharm. Stat. 8:1-15.
14. Lin, K. K., Ali, M. W. (2006). Statistical review and evaluation of animal carcinogenicity studies. In: Buncher, C. R., Tsay, J. Y. eds. Statistics in the Pharmaceutical Industry. 3rd ed. New York: Chapman & Hall/CRC, Inc.
15. Peto, R., Pike, M. C., Day, N. E., Gray, R. G., Lee, P. N., Parish, S., Peto, J., Richards, S., Wahrendorf, J. (1980). Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. Long-term and Short-term Screening Assays for Carcinogens: A Critical Appraisal. World Health Organization.
16. Woodruff, R. S. (1971). A simple method for approximating the variance of a complicated estimate. J. Am. Stat. Assoc. 66:411-414.
17. U.S. Department of Human Health and Services. (2001). Guidance for Industry: Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals. Silver Spring, MD: Center for Drug Evaluation and Research, Food and Drug Administration.